MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer

NCT02041481 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Colon Cancer
Recurrent Rectal Cancer
Stage IVA Colon Cancer
Stage IVA Rectal Cancer
Stage IVB Colon Cancer
Stage IVB Rectal Cancer

Interventions

DRUG: MEK inhibitor MEK162
DRUG: leucovorin calcium
DRUG: fluorouracil
DRUG: oxaliplatin
OTHER: pharmacological study
OTHER: Laboratory Biomarker Analysis

Sponsor

City of Hope Medical Center

Collaborators

[object Object]
[object Object]